InspireMD (NSPR) Cost of Revenue (2010 - 2026)

InspireMD has reported Cost of Revenue for 17 years, with the latest figure at $2.5 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 73.72% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $8.9 million, a 59.27% increase from a year earlier, with the FY2025 full-year figure at $6.3 million, up 15.03% from the prior year.
• Cost of Revenue was $2.5 million for Q2 2026 at InspireMD, down from $2.7 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.7 million in Q1 2026, with the low at $828000.0 in Q4 2022.
• Average Cost of Revenue over 5 years is $1.4 million, with a median of $1.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Cost of Revenue slipped 23.76% in 2022, then surged 119.16% in 2026.
• Over 5 years, Cost of Revenue stood at $828000.0 in 2022, then surged by 51.69% to $1.3 million in 2023, then increased by 17.83% to $1.5 million in 2024, then soared by 33.04% to $2.0 million in 2025, then rose by 29.25% to $2.5 million in 2026.
• The last three Cost of Revenue figures came in at $2.5 million (Q2 2026), $2.7 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.